Brazil's Hypera to sell Xantinon drug to Uniao Quimica

Ref: Fidelity
  • According to a securities filing, Hypera has agreed to sell the medicine Xantinon to¬†Uniao Quimica Farmaceutica Nacional for BRL 95 million, as reported in Fidelity.

  • Xantinon was part of a portfolio of 18 products Hypera acquired from Takeda for $825 million earlier in March.